These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22968336)

  • 1. Pharmacokinetics and pharmacodynamics of ciprofloxacin in critically ill patients after the first intravenous administration of 400 mg.
    Szałek E; Tomczak H; Kamińska A; Grabowski T; Smuszkiewicz P; Matysiak K; Wolc A; Kaczmarek Z; Grześkowiak E
    Adv Med Sci; 2012; 57(2):217-23. PubMed ID: 22968336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciprofloxacin pharmacokinetics in critically ill patients: a prospective cohort study.
    van Zanten AR; Polderman KH; van Geijlswijk IM; van der Meer GY; Schouten MA; Girbes AR
    J Crit Care; 2008 Sep; 23(3):422-30. PubMed ID: 18725050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of total and partial nephrectomy on the elimination of ciprofloxacin in humans.
    Szałek E; Połom W; Karbownik A; Grabowski T; Konkołowicz A; Wolc A; Matuszewski M; Krajka K; Grześkowiak E
    Pharmacol Rep; 2012; 64(3):673-9. PubMed ID: 22814020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of gatifloxacin pharmacokinetics and pharmacodynamics in severely ill adults in a medical Intensive Care Unit.
    Fish DN
    Int J Antimicrob Agents; 2007 Jun; 29(6):715-23. PubMed ID: 17433631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PK/PD index (CMAX/MIC) for ciprofloxacin in patients with cystic fibrosis.
    Szałek E; Kamińska A; Gozdzik-Spychalska J; Grześkowiak E; Batura-Gabryel H
    Acta Pol Pharm; 2011; 68(5):777-83. PubMed ID: 21928725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of pharmacokinetics/ pharmacodynamics of ciprofloxacin between 400 mg intravenously every 8 h and 400 mg intravenously every 12 h in patients with gram negative bacilli bacteremia.
    Saengsuwan P; Jaruratanasirikul S; Jullangkoon M; Aeinlang N
    J Med Assoc Thai; 2010 Jul; 93(7):784-8. PubMed ID: 20649056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and burn eschar penetration of intravenous ciprofloxacin in patients with major thermal injuries.
    Varela JE; Cohn SM; Brown M; Ward CG; Namias N; Spalding PB
    J Antimicrob Chemother; 2000 Mar; 45(3):337-42. PubMed ID: 10702553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciprofloxacin pharmacokinetic profiles in paediatric sepsis: how much ciprofloxacin is enough?
    Lipman J; Gous AG; Mathivha LR; Tshukutsoane S; Scribante J; Hon H; Pinder M; Riera-Fanego JF; Verhoef L; Stass H
    Intensive Care Med; 2002 Apr; 28(4):493-500. PubMed ID: 11967606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciprofloxacin use in critically ill patients: pharmacokinetic and pharmacodynamic approaches.
    Conil JM; Georges B; de Lussy A; Khachman D; Seguin T; Ruiz S; Cougot P; Fourcade O; Houin G; Saivin S
    Int J Antimicrob Agents; 2008 Dec; 32(6):505-10. PubMed ID: 18768301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis.
    Montgomery MJ; Beringer PM; Aminimanizani A; Louie SG; Shapiro BJ; Jelliffe R; Gill MA
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3468-73. PubMed ID: 11709326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and absolute bioavailability of ciprofloxacin administered through a nasogastric tube with continuous enteral feeding to critically ill patients.
    Mimoz O; Binter V; Jacolot A; Edouard A; Tod M; Petitjean O; Samii K
    Intensive Care Med; 1998 Oct; 24(10):1047-51. PubMed ID: 9840238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in goats given enrofloxacin alone and in combination with probenecid.
    Rao GS; Ramesh S; Ahmad AH; Tripathi HC; Sharma LD; Malik JK
    Vet J; 2002 Jan; 163(1):85-93. PubMed ID: 11749141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of ciprofloxacin after single intravenous and repeat oral administration to cats.
    Albarellos GA; Kreil VE; Landoni MF
    J Vet Pharmacol Ther; 2004 Jun; 27(3):155-62. PubMed ID: 15189301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of a novel extended-release ciprofloxacin in healthy volunteers.
    Washington CB; Hou SY; Campanella C; Hughes N; Brown S; Berner B
    J Clin Pharmacol; 2005 Nov; 45(11):1236-44. PubMed ID: 16239356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic parameters of ciprofloxacin (500 mg/5 mL) oral suspension in critically ill patients with severe bacterial pneumonia: a comparison of two dosages.
    Debon R; Breilh D; Boselli E; Saux MC; Duflo F; Chassard D; Allaouchiche B
    J Chemother; 2002 Apr; 14(2):175-80. PubMed ID: 12017373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciprofloxacin pharmacokinetics in burn patients.
    Garrelts JC; Jost G; Kowalsky SF; Krol GJ; Lettieri JT
    Antimicrob Agents Chemother; 1996 May; 40(5):1153-6. PubMed ID: 8723457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ciprofloxacin target AUC : MIC ratio is not reached in hospitalized patients with the recommended dosing regimens.
    Haeseker M; Stolk L; Nieman F; Hoebe C; Neef C; Bruggeman C; Verbon A
    Br J Clin Pharmacol; 2013 Jan; 75(1):180-5. PubMed ID: 22616681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetic modeling and Monte Carlo simulation of varying doses of intravenous metronidazole.
    Sprandel KA; Drusano GL; Hecht DW; Rotschafer JC; Danziger LH; Rodvold KA
    Diagn Microbiol Infect Dis; 2006 Aug; 55(4):303-9. PubMed ID: 16887471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The administration of ciprofloxacin during continuous renal replacement therapy: pilot study.
    Hayakawa M; Fujita I; Iseki K; Gando S
    ASAIO J; 2009; 55(3):243-5. PubMed ID: 19318919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin in ill cows.
    Fu LX; Jiang ZG; Ding HZ; Liu YH
    J Vet Pharmacol Ther; 2008 Jun; 31(3):240-5. PubMed ID: 18471145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.